Publication
New rules for MDEL holders: Health Canada’s terms and conditions authority
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
United Kingdom | Publication | September 2022
The CMG scheme had experienced problems following historical mistakes made in the execution of rule amendments relating to the equalisation of normal retirement date for all members and a reduction in the accrual rate.
The scheme rules included the following provision:
Members had been paid lump sums in compensation for underpayments but the employer claimed that the above rule closed off this avenue after six years. The Trustee argued that the rule was merely intended to free up orphaned benefits and identifying missing beneficiaries. The Trustee’s claim was that identifiable members’ benefits were not extinguished, and shortfalls of historic benefits should still be paid.
The court also decided that where trustees seek to recover overpaid benefits by reducing members’ future benefit payments, a county court order is required and a direction from the Pensions Ombudsman will not suffice.
The Lloyds judgment discounted any possibility of a statutory limitation applying to payment of arrears of GMP equalisation benefits but after this judgment it is possible that certain scheme rules may mean limitation applies, depending on the particular way the relevant provisions are expressed.
Publication
Amendments to the Medical Devices Regulations affecting the regulatory framework for medical device establishment licences (MDEL) are now in effect.
Publication
Early January is a good time to take stock of workplace law developments that arose in 2024, and how those developments may evolve in 2025.
Publication
As you prepare for your next AGM, stay up-to-date on key developments in Canadian corporate and securities legislation, corporate governance guidance and institutional shareholder proxy voting guidelines that may impact the management information circular for your 2025 annual shareholder meeting and your 2025 annual disclosure filings.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2025